USCS 2014 Data Released
The United States Cancer Statistics (USCS)incidence and mortality data for the period 1999–2014 have been released. Tables and graphs showing the data are available, and the information is broken down by state, age, sex, and more in a visual format in the new Data Visualizations tool.
New Report in MMWR Series Looks at Cancer in Rural Areas
“Invasive Cancer Incidence, 2004–2013, and Deaths, 2006–2015, in Nonmetropolitan (Rural or Urban) and Metropolitan Counties—United States,” led by Jane Henley, MSPH and co-authored by numerous DCPC scientists, is the latest in a series in MMWR about rural health. The article shows that people living in rural areas have higher death rates from cancer, and that death rates went down at a slower pace in rural than in urban counties.
Bring Your Brave Debuts on Tumblr!
DCPC’s Bring Your Brave campaign, which educates young women and health care providers about breast cancer in young women, now has a community on Tumblr! This new Tumblr account is for young breast cancer survivors, previvors, and caregivers who want to share their story about their experience with breast cancer. This is CDC’s first Tumblr account and we are really excited about moving into this social media platform. Check us out and let us know if you have any questions!
Dr. Richardson Hosts Panel at Cancer Moonshot: One Year Later Meeting
Dr. Lisa Richardson, Director of DCPC, moderated the Preventing Cancer panel at the Cancer Moonshot: One Year Later meeting hosted by the Cancer Support Community. Speakers included Elmer Huerta, MD, MPH, Director, Cancer Preventorium, MedStar Washington Hospital Center’s Washington Cancer Institute; Beth Meagher, Federal Strategy Leader, Deloitte Consulting, LLP; and Debbie Saslow, PhD, Director, Cancer Control Intervention for HPV Vaccination & Women’s Cancer, American Cancer Society. Panelists gave one-year updates on their commitments made for the Moonshot Initiative last year.
DCPC Co-Funds Report on Elimination of Hepatitis B and C
A new report, “A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report,” was funded in part by DCPC. The report was released by the National Academies of Science, Engineering, and Medicine, and is available for download.
Workshop Proceedings Now Available
Greta Massetti, PhD led the planning committee for a workshop entitled “Implementation of Lung Cancer Screening.” The proceedings for this gathering, published by the National academies of Science, Engineering, and Medicine, are available online. The publication summarizes the workshop discussion about the current evidence base for lung cancer screening, the current challenges of implementation, and opportunities to overcome them.
Register Now for the Cancer Conference!
Don’t forget to register for the 2017 CDC National Cancer Conference, to take place in Atlanta from August 14–16!
DCPC’s Latest Publications
- “Ovarian Cancer Knowledge in Women and Providers Following Education with Inside KnowledgeCampaign Materials,” led by Mary Puckett, PhD, demonstrates that knowledge of ovarian cancer facts increased in women after exposure to materials from CDC’s Inside Knowledge: Get the Facts about Gynecologic Cancer campaign.
- “A Qualitative Analysis of Smokers' Perceptions About Lung Cancer Screening,” led by Lindsay Gressard, MPH, showed that few participants in a study of active smokers in the recommended age range had been screened for lung cancer, and those who had recalled little about the test.
- “Use of Community Health Workers and Patient Navigators to Improve Cancer Outcomes Among Patients Served by Federally Qualified Health Centers: A Systematic Literature Review,” led by Kate Roland, MPH, found that evidence supports the effectiveness of community health workers and patient navigators in getting people timely breast, cervical, and colorectal cancer screening.
- Hannah Weir, PhD was a contributing author to the article, “The TNM Classification of Malignant Tumors—Towards Common Understanding and Reasonable Expectations.” The piece seeks to clarify the benefit of the TNM (tumor, [affected lymph] nodes, metastasis) classification system for use in global cancer control.